White Matter Lesion Progression: Genome-Wide Search for Genetic Influences
暂无分享,去创建一个
Benjamin F. J. Verhaaren | M. Fornage | A. Hofman | T. Lumley | C. DeCarli | V. Gudnason | Albert Vernon Smith | Qiong Yang | B. Mazoyer | B. Psaty | A. Zijdenbos | W. Niessen | N. Sattar | K. Taylor | M. van Buchem | P. Amouyel | A. D. de Craen | P. Slagboom | C. V. van Duijn | V. Srikanth | C. Dufouil | R. Westendorp | C. Tzourio | R. Schmidt | H. Schmidt | G. Heiss | M. Vernooij | M. Ikram | A. Beiser | J. Bis | L. Launer | T. Mosley | S. Seshadri | M. Callisaya | J. Jukema | C. Duijn | C. Wolf | Hieab H. H. Adams | G. Chauhan | C. Satizabal | S. Debette | S. Trompet | B. Buckley | D. Stott | I. Ford | A. Craen | T. Phan | R. Thomson | S. Sigurdsson | W. Longstreth | R. Beare | E. Hofer | O. Martinez | R. Gottesman | M. Cavalieri | D. Shibata | C. Moran | B. Windham | B. Verhaaren | P. Freudenberger | Sabrina Schilling | A. Töglhofer | Jing Wang | B. Gwen Windham | A. Smith | M. Buchem | A. Smith | P. Slagboom | A. Hofman | B. Psaty | R. Schmidt
[1] John Blangero,et al. MACROD2 gene associated with autistic-like traits in a general population sample , 2014, Psychiatric genetics.
[2] S. O'Bryant,et al. Arsenic exposure, AS3MT polymorphism, and neuropsychological functioning among rural dwelling adults and elders: a cross-sectional study , 2014, Environmental Health.
[3] Cai,et al. GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS REVEALS TRANS-ETHNIC REPLICATION OF MEAN ARTERIAL AND PULSE PRESSURE LOCI , 2022 .
[4] S. Ropele,et al. Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. , 2013, Brain : a journal of neurology.
[5] Simon C. Potter,et al. Genome-wide Association Analysis Identifies 14 New Risk Loci for Schizophrenia , 2013, Nature Genetics.
[6] A. Hofman,et al. The healthy volunteer effect and coronary risk prediction in the general population: the Rotterdam study , 2013 .
[7] D. Rujescu,et al. A comprehensive family-based replication study of schizophrenia genes. , 2013, JAMA psychiatry.
[8] Kaitlin M. Fitzpatrick,et al. 17q25 Locus Is Associated With White Matter Hyperintensity Volume in Ischemic Stroke, But Not With Lacunar Stroke Status , 2013, Stroke.
[9] K. Kohara,et al. Association of Chr17q25 with cerebral white matter hyperintensities and cognitive impairment: the J‐SHIPP study , 2013, European journal of neurology.
[10] M. Daly,et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.
[11] R. Schmidt,et al. Genetics of age-related white matter lesions from linkage to genome wide association studies , 2012, Journal of the Neurological Sciences.
[12] R. Handsaker,et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder , 2012, Molecular Psychiatry.
[13] Nicholas R. Lemoine,et al. SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update) , 2012, Nucleic Acids Res..
[14] Christina N. Lessov-Schlaggar,et al. Longitudinal genetic analysis of brain volumes in normal elderly male twins , 2012, Neurobiology of Aging.
[15] Benjamin F. J. Verhaaren,et al. Replication Study of Chr17q25 With Cerebral White Matter Lesion Volume , 2011, Stroke.
[16] M. Fornage,et al. Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease , 2011, Brain : a journal of neurology.
[17] Anders D. Børglum,et al. Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.
[18] Christian Gieger,et al. Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk , 2011, Nature.
[19] M. Fornage,et al. Genome‐wide association studies of cerebral white matter lesion burden , 2011, Annals of neurology.
[20] N. Mehta. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.
[21] D. Levy,et al. Discovery and replication of novel blood pressure genetic loci in the Women's Genome Health Study , 2011, Journal of hypertension.
[22] Boer,et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE Consortium , 2011 .
[23] Michael Boehnke,et al. LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..
[24] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[25] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[26] Alejandro F. Frangi,et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci , 2010, Nature genetics.
[27] M. Fornage,et al. Genome-Wide Association Studies of MRI-Defined Brain Infarcts: Meta-Analysis From the CHARGE Consortium , 2010, Stroke.
[28] C. Jack,et al. Blood Pressure and White-Matter Disease Progression in a Biethnic Cohort: Atherosclerosis Risk in Communities (ARIC) Study , 2010, Stroke.
[29] N. Obuchowski,et al. Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.
[30] Vilmundur Gudnason,et al. Glycemic Status and Brain Injury in Older Individuals , 2009, Diabetes Care.
[31] Carole Dufouil,et al. White matter lesions volume and motor performances in the elderly , 2009, Annals of neurology.
[32] P. O’Reilly,et al. Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.
[33] C. Sudlow,et al. Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects , 2009, Stroke.
[34] Wiro J. Niessen,et al. White matter lesion extension to automatic brain tissue segmentation on MRI , 2009, NeuroImage.
[35] K. Lunetta,et al. Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .
[36] Richard Beare,et al. Cerebral White Matter Lesions, Gait, and the Risk of Incident Falls: A Prospective Population-Based Study , 2009, Stroke.
[37] Monique M. B. Breteler,et al. The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.
[38] B. Mazoyer,et al. Longitudinal follow-up of individual white matter hyperintensities in a large cohort of elderly , 2009, Neuroradiology.
[39] Andrew D. Johnson,et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..
[40] Wiro J. Niessen,et al. Brain tissue volumes in the general elderly population The Rotterdam Scan Study , 2008, Neurobiology of Aging.
[41] P. Macfarlane,et al. Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. , 2008, Brain : a journal of neurology.
[42] Carole Dufouil,et al. White Matter Lesions as a Predictor of Depression in the Elderly: The 3C-Dijon Study , 2008, Biological Psychiatry.
[43] O. Lopez,et al. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[44] A. Hofman,et al. Incidental findings on brain MRI in the general population. , 2007, The New England journal of medicine.
[45] Qiong Yang,et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. , 2007, American journal of epidemiology.
[46] V. Gudnason,et al. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. , 2007, American journal of epidemiology.
[47] G. Waldemar,et al. The apolipoprotein E ɛ4‐allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities , 2007 .
[48] K. Lunetta,et al. Heritability of Magnetic Resonance Imaging (MRI) Traits in Alzheimer Disease Cases and Their Siblings in the MIRAGE Study , 2007, Alzheimer disease and associated disorders.
[49] A. Hofman,et al. Polymorphisms of the renin–angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[50] G. Waldemar,et al. The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities. , 2007, Acta neurologica Scandinavica.
[51] B. Mazoyer,et al. An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases , 2007, Neuroradiology.
[52] Sudha Seshadri,et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. , 2006, JAMA.
[53] A. Berghold,et al. C-Reactive Protein, Carotid Atherosclerosis, and Cerebral Small-Vessel Disease: Results of the Austrian Stroke Prevention Study , 2006, Stroke.
[54] H. Markus,et al. Polymorphisms in Genes of the Renin-Angiotensin System and Cerebral Small Vessel Disease , 2006, Cerebrovascular Diseases.
[55] P. Wolf,et al. The lifetime risk of stroke: estimates from the Framingham Study. , 2006, Stroke.
[56] Johan H. C. Reiber,et al. Fully automatic segmentation of white matter hyperintensities in MR images of the elderly , 2005, NeuroImage.
[57] D. Harvey,et al. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.
[58] Norman J Beauchamp,et al. Incidence, Manifestations, and Predictors of Worsening White Matter on Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2005, Stroke.
[59] N. Pedersen,et al. Quantitative genetic analysis of latent growth curve models of cognitive abilities in adulthood. , 2005, Developmental psychology.
[60] Charles DeCarli,et al. Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study , 2004, Stroke.
[61] Charles DeCarli,et al. Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.
[62] Jan Cees de Groot,et al. Interaction Between Hypertension, apoE, and Cerebral White Matter Lesions , 2004, Stroke.
[63] M. Fornage,et al. Heritability of Leukoaraiosis in Hypertensive Sibships , 2004, Hypertension.
[64] A. Hofman,et al. Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.
[65] Hugh S Markus,et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. , 2004, Brain : a journal of neurology.
[66] R. Holman,et al. Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.
[67] K. Kohara,et al. MTHFR Gene Polymorphism as a Risk Factor for Silent Brain Infarcts and White Matter Lesions in the Japanese General Population: The NILS-LSA Study , 2003, Stroke.
[68] A. Hofman,et al. Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.
[69] A. Hofman,et al. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study , 2003, Journal of neurology, neurosurgery, and psychiatry.
[70] Oscar L. Lopez,et al. Evaluation of Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.
[71] P. Macfarlane,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.
[72] Alan C. Evans,et al. Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis , 2002, IEEE Transactions on Medical Imaging.
[73] K. Christensen,et al. The Heritability of Level and Rate-of-Change in Cognitive Functioning in Danish Twins Aged 70 Years and Older , 2002, Experimental aging research.
[74] M. Soleimani. Na+:HCO3- cotransporters (NBC): expression and regulation in the kidney. , 2002, Journal of nephrology.
[75] J. Bamford,et al. Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes , 2002, Journal of neurology, neurosurgery, and psychiatry.
[76] A. de la Sierra,et al. Renin-Angiotensin System Genetic Polymorphisms and Cerebral White Matter Lesions in Essential Hypertension , 2002, Hypertension.
[77] F. Fazekas,et al. Angiotensinogen Polymorphism M235T, Carotid Atherosclerosis, and Small-Vessel Disease-Related Cerebral Abnormalities , 2001, Hypertension.
[78] C. Furberg,et al. Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study , 2001, Neurology.
[79] P. Macfarlane,et al. The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. , 1999, The American journal of cardiology.
[80] F. Fazekas,et al. MRI white matter hyperintensities , 1999, Neurology.
[81] A. Folsom,et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. , 1999, Stroke.
[82] L. Wahlund,et al. White Matter Lesions in Alzheimer Patients Are Influenced by Apolipoprotein E Genotype , 1999, Dementia and Geriatric Cognitive Disorders.
[83] M. Soleimani,et al. Characterization of Na+/HCO-3 cotransporter isoform NBC-3. , 1999, The American journal of physiology.
[84] G. Wilcock,et al. Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population , 1998, International journal of geriatric psychiatry.
[85] B L Miller,et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.
[86] M. Kraut,et al. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. , 1998, Stroke.
[87] L. Almasy,et al. Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.
[88] A. Hoes,et al. Prevalence of stroke in the general population. The Rotterdam Study. , 1996, Stroke.
[89] Teri,et al. A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. , 1994, AJNR. American journal of neuroradiology.
[90] F. Fazekas,et al. Assessment of cerebrovascular risk profiles in healthy persons: definition of research goals and the Austrian Stroke Prevention Study (ASPS). , 1994, Neuroepidemiology.
[91] B. Horwitz,et al. Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. , 1992, Journal of computer assisted tomography.
[92] N. Nagelkerke,et al. A note on a general definition of the coefficient of determination , 1991 .
[93] R. Kronmal,et al. The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.
[94] P. Allhoff,et al. The Framingham Offspring Study , 1991 .
[95] Aric Invest. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators , 1989 .
[96] A. Folsom,et al. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.
[97] H Lechner,et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. , 1988, Stroke.
[98] R F Spetzler,et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. , 1986, Stroke.
[99] W. Kannel,et al. The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.
[100] W. Kannel,et al. The Framingham Study An Epidemiological Approach to Coronary Heart Disease , 1966, Circulation.